Vimarsana
Biggest News Aggregation in the World

Page 47 - Heca News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Heca. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Heca Today - Breaking & Trending Today

India tax dept searches Mankind Pharma's office -source - Vimarsana News

India tax dept searches Mankind Pharma's office -source

India's income tax department is conducting searches at Mankind Pharma Ltd's office in New Delhi, two government sources told Reuters on Thursday, days after the condom maker's successful public listing on domestic stock exchanges.

Immunitybio slumps as FDA declines to approve bladder cancer treatment - Vimarsana News

Immunitybio slumps as FDA declines to approve bladder cancer treatment

ImmunityBio Inc said on Thursday the U.S. Food and Drug Administration has declined to approve its combination therapy to treat a type of bladder cancer due to deficiencies in the company's application.

Italy's Angelini invests up to $506 mln in Japan's JCR for epilepsy drug - Vimarsana News

Italy's Angelini invests up to $506 mln in Japan's JCR for epilepsy drug

Family-owned Italian industrial conglomerate Angelini is set to invest up to $505.5 million to fund development of a new treatment for epilepsy by Japan's JCR Pharmaceuticals , capable of penetrating the blood-brain barrier.

Eisai, Biogen Alzheimer's drug Leqembi would cost US Medicare up to $5 bln a year, study finds - Vimarsana News

Eisai, Biogen Alzheimer's drug Leqembi would cost US Medicare up to $5 bln a year, study finds

Wide coverage of Alzheimer's drug Leqembi would raise future costs for the U.S. Medicare health plan by $2 billion to $5 billion a year, according to a study led by researchers at the University of California, Los Angeles (UCLA).

China's fresh COVID wave raises concern of trading volume slowdown - Vimarsana News

China's fresh COVID wave raises concern of trading volume slowdown

A fresh wave of COVID-19 is spreading through China as people return from public holiday travel, reaching trading floors and raising concern of an impact to trading volume - albeit likely not as pronounced as previous pandemic-induced disruption.